Even with minimal inflammation, modifiable psychological and behavioral factors strongly influence fatigue, pain, and fecal incontinence in patients with inflammatory bowel disease.
Even with minimal inflammation, modifiable psychological and behavioral factors strongly influence fatigue, pain, and fecal incontinence in patients with inflammatory bowel disease.
Vitamin D supplementation in clinical practice is associated with reduced corticosteroid use and fewer acute care encounters among patients with inflammatory bowel disease.
Vitamin D supplementation in clinical practice is associated with reduced corticosteroid use and fewer acute care encounters among patients with inflammatory bowel disease.
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Dr Pabla discussed the importance of focusing on the clinical history and other concomitant medications when diagnosing IBD, and the use of ultrasound, biomarkers and other modalities when monitoring patients' conditions.
Dr Pabla discussed the importance of focusing on the clinical history and other concomitant medications when diagnosing IBD, and the use of ultrasound, biomarkers and other modalities when monitoring patients' conditions.
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Estimates vary but indicate that half or more of patients with Crohn's disease will require surgery at some point in their disease course. Do you know which factors place your patients at high risk for surgery? Take our quiz to find out!
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
Clinicians should remain mindful of predictors of reduced treatment success, such as perianal involvement and steroid dependency, when selecting candidates for advanced combination treatment.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
A large cohort study reveals key factors linked to multiple extraintestinal manifestations in inflammatory bowel disease, offering new insights into personalized treatment approaches.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Freddy Caldera, DO, PhD, and IBD Drive Time cohost Millie Long, MD, discuss the new AGA best practice advice on preventing diseases and monitoring for complications in patients with inflammatory bowel disease.
Raymond Cross, MD; Millie D. Long, MD, MPH; Jessica Korman
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Andrea Bafford, MD, and Jessica Korman, MD, join Drs Raymond Cross and Millie Long to review the challenges of detecting, diagnosing, and managing anorectal cancer among patients with inflammatory bowel disease.
Jami Kinnucan; Raymond Cross, MD; Millie D. Long, MD, MPH
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
Jami Kinnucan, MD, reviews the facts and fallacies about the use of cannabis for the treatment of inflammatory bowel disease, and how to discuss the issue with patients, with IBD Drive Time hosts Raymond Cross, MD, and Millie Long, MD.
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.Â
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study.Â
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Dr Regueiro and IBD Drive Time host Raymond Cross, MD, discuss the importance and the challenges of providing multidisciplinary care to patients with IBD, including dietary guidance, mental health services, and more.
Dr Regueiro and IBD Drive Time host Raymond Cross, MD, discuss the importance and the challenges of providing multidisciplinary care to patients with IBD, including dietary guidance, mental health services, and more.
Guest host Sara Horst, MD, talks with Dr Ed Barnes about his research into whether antibiotics taken a year before an IPAA may contribute to the development of pouchitis.
Guest host Sara Horst, MD, talks with Dr Ed Barnes about his research into whether antibiotics taken a year before an IPAA may contribute to the development of pouchitis.
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
